Attached files

file filename
10-Q - QUARTERLY REPORT - Sunshine Biopharma, Incsbfm_10q.htm
EX-31.2 - CERTIFICATION - Sunshine Biopharma, Incsbfm_ex312.htm
EX-31.1 - CERTIFICATION - Sunshine Biopharma, Incsbfm_ex311.htm
EXCEL - IDEA: XBRL DOCUMENT - Sunshine Biopharma, IncFinancial_Report.xls
Exhibit 32

CERTIFICATION PURSUANT TO
18 USC, SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report of Sunshine Biopharma, Inc. (the “Company”) on Form 10-Q for the nine month period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, the undersigned, in the capacities and on the date indicated below, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 
1.
The Report fully complies with the requirements of Rule 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

     
       
Dated:  November 4, 2013
  /s/ Steve N. Slilaty  
   
Steve N. Slilaty, Chief Executive Officer
 
       

       
Dated:  November 4, 2013
  /s/ Camille Sebaaly  
   
Camille Sebaaly, Chief Financial Officer